RESEARCH ATLASRESEARCH > HYPE
PUBLIC RESEARCH EDITION
Metabolic / appetite

Adipotide

Mechanism not verified by source image · Peptide

Evidence at a glance

Each record keeps its own evidence class. Counts are records in this public edition, not a quality score.

Open in the interactive library →Compare with other compounds →

Records (1)

P

Preclinical

Preclinical

Adipotide in obese rhesus macaques

Administration reported for this specific study or labeled indication.

Context: 15 obese rhesus macaques including controls

Animal study regimen: Amount: 0.43 mg/kg; Route: Subcutaneous; Frequency: Daily; Duration: 28 days of dosing, 28 days of recovery; Species: Rhesus macaque; Population: 15 obese rhesus macaques including controls

Limitations: The study tracked anthropometric outcomes and reported renal proximal tubule effects.

Route: Subcutaneous

Open this exact record in the library →Suggest a correction
CONTINUE THE RESEARCH

Follow the pathway.

These compounds share an Atlas pathway label. That is a navigation connection, not evidence of equivalent effects or suitability together.

5-Amino-1MQ7 labeled records →AOD-96043 labeled records →Cagrilintide3 labeled records →Eloralintide2 labeled records →Mazdutide1 labeled records →O304 / ATX-304 research4 labeled records →
Browse this pathway in the library →

Educational research summary. Study amounts are research context, not a dose recommendation. Not medical advice.